SensAbues Competitors and Similar CompaniesClear all
SensAbues's competitors and similar companies include ChemoSen3D, NMS Labs, More Diagnostics and Exagen.
 ChemoSen3D ChemoSen3D (formerly Nano3D Biosciences) is a company that develops an approach to personalized treatment to deliver recommendations. |  NMS Labs NMS Labs (also known as National Medical Services) is a company providing esoteric, clinical, and forensic toxicology and drug identification services. |  Exagen Exagen is a biotechnology company engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. | |||
Founding Date | Founding Date 2009 | Founding Date 2008 | Founding Date 1970 | Founding Date 1985 | Founding Date 2002 |
Type | Type Private | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Stockholm, SE HQ Västerås, SE | Locations Houston, US HQ | Locations Horsham, US HQ Grand Prairie, US Willow Grove, US | Locations Baywood-Los Osos, US HQ | Locations Vista, US HQ |
Employees | Employees 1 | Employees 5 | Employees 4241% increase | Employees 167% increase | Employees 144 |
For sources of this data, please see the company profile
View Company Profiles
ChemoSen3D
HQ
Houston, US
Employees
5
ChemoSen3D (formerly Nano3D Biosciences) is a company that develops an approach to personalized treatment to deliver recommendations.
View companyNMS Labs
HQ
Horsham, US
Employees
424↑ 1% increase
NMS Labs (also known as National Medical Services) is a company providing esoteric, clinical, and forensic toxicology and drug identification services.
View company
More Diagnostics
HQ
Baywood-Los Osos, US
Employees
16↑ 7% increase
More Diagnostics is a company providing quality controls for clinical diagnostics.
View companyExagen
HQ
Vista, US
Employees
144
Exagen is a biotechnology company engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention.
View company